Our previous work has shown that wild type (WT) Nav1.7 exhibits a limited capability to generate Navβ4 peptide INaR, although paroxysmal extreme pain disorder (PEPD) mutations that impair inactivation can substantially enhance Nav1.7 INaR (Theile et al., 2011). The gene discussed is SCN9A; the disease is paroxysmal extreme pain disorder.